Cancer Genetics (CGIX)

Add to Watchlists
Create an Alert
2.66 +0.00  +0.00% NASDAQ Apr 29, 21:57 Delayed 2m USD
View Full Chart
CGIX Price Chart
View All Performance Charts

CGIX Total Returns Comparison

Advertisement

Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • URL: http://www.cancergenetics.com
  • Investor Relations URL: http://ir.cancergenetics.com/
  • HQ Country: United States
  • HQ State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Electromedical and Electrotherapeutic Apparatus Manufacturing
  • NAICS Code: 334510
  • NAICS Industry Name: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Cancer Genetics Inc is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and engages in improving and personalizing the diagnosis, prognosis and response to treatment of cancer.

CGIX Comparables

Edit

CGIX Excel Add-In Codes

  • Name: =YCI("CGIX","name")
  • Description: =YCI("CGIX","description")
  • Sector: =YCI("CGIX","sector")
  • Industry: =YCI("CGIX","industry")
  • Est. Current Fiscal Year End: =YCI("CGIX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.